Growing Market Presence Magnus Medical has significantly expanded its partner network across 14 states by collaborating with prominent health systems such as Cleveland Clinic, UPMC, HCA Healthcare, and others, indicating a strong foothold and increasing demand for its brain stimulation technology in major healthcare institutions.

Expanding Patient Access With their recent partnership launches scheduled throughout 2026, there is a clear opportunity to engage with hospitals and clinics involved in mental health treatment, positioning Magnus as a key provider of innovative therapies for neuropsychiatric disorders.

Innovative Technology Adoption Magnus' FDA-cleared SAINT Neuromodulation System targets treatment-resistant depression, highlighting its focus on advanced medical devices that address unmet needs, making it attractive for healthcare providers seeking breakthrough mental health solutions.

Revenue Growth Potential Currently generating between 10 to 25 million dollars in revenue with a relatively lean team, Magnus presents a compelling growth story, offering opportunities for sales expansion through increasing device adoption and new health system contracts.

Industry Competitive Edge Positioned among healthtech and medical device innovators, Magnus’ focus on breakthrough regulatory status and expanding partnerships creates opportunities to introduce complementary digital solutions, training programs, or support services to healthcare organizations.